Jim Cramer Highlighted Buying Opportunities in 13 Stocks

5. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders: 63

Abbott Laboratories (NYSE:ABT) is an international healthcare company dedicated to the discovery, development, production, and sale of a diverse range of healthcare products. Cramer highlighted how the company, despite its lawsuit, has been able to trek upward.

“And we saw this with Abbott Labs, ABT, not that long ago when it lost a lawsuit involving a special infant formula that some agree, parents thought harmed their baby. The formula was made by Abbott because women sometimes just can’t produce enough milk. Abbott only made $9 million a year on it.

I think that they actually own this formula. I think they do it at the behest of the government or just out of, literally out of their hearts, but it doesn’t matter. They lost a $500 million lawsuit, $500 million. And now I told you to dismiss it, not worry about it. Sure enough, what happened? Abbott stock is now up more than 30 points from that event.”